Taking into account the patient reported by Haugarvoll et al. [11], who also developed a liver tumor, this underlines the need for awareness of the possibility of developing liver cancer in these patients and warrants screening for liver fibrosis and liver tumors in AMACR deficiency patients. This evidence concerns the gene AMACR and Hepatic fibrosis.